Important for clinical trials: https://jamanetwork.com/journals/jama/fullarticle/2825290?guestAccessKey=51072d5e-65f9-4d00-9bf0-e2e90e163234&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=101924&adv=000004551719
Update here: https://jamanetwork.com/journals/jama/fullarticle/2825290?guestAccessKey=51072d5e-65f9-4d00-9bf0-e2e90e163234&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=101924&adv=000004551719 Special remark on patients view: (Citation) The latest revision1 introduces important updates that align with modern scientific advances and the evolving societal understanding of patient rights. For example,
netwOArk member Helen French et al. have published and analysis of pain. pain subgroups and pain medication use in a cohort in Ireland: https://pubmed.ncbi.nlm.nih.gov/39358713/ This study found that medication use among
netwOArk member Helen French et al. have published and analysis of pain. pain subgroups and pain medication use in a cohort in Ireland: https://pubmed.ncbi.nlm.nih.gov/39358713/ This study found that medication use
EULAR recommendations for the involvement ofpatient research partners in rheumatology research:2023 update published: 2024 EULAR recommendations for involvement of patients
